Literature DB >> 28560764

Incidence of sleep disturbances in patients with familial Mediterranean fever and the relation of sleep quality with disease activity.

Orhan Kucuksahin1, Ahmet Omma2, Ali Erhan Ozdemirel3, Duygu Tecer4, Sümeyye Ulutas5, Yüksel Maras6, Ayşe Balkarlı7, Şükran Erten1.   

Abstract

AIM: To evaluate the sleep quality and the relation of sleep quality with depression, anxiety, fatigue and disease activity in adult patients with familial Mediterranean fever (FMF).
METHOD: One hundred and seventy-four FMF patients and 84 age-sex matched healthy individuals were included in this study. The Pittsburgh Sleep Quality Index (PSQI), Multidimensional Assessment of Fatigue (MAF) and the Hospital Anxiety and Depression Index (HADS) were used to assess sleep quality, fatigue, depression and anxiety, respectively. RESULT: FMF patients had significantly higher depression, anxiety, fatigue and PSQI scores than healthy controls. As the severity of the disease increased, scores of total PSQI and its domains increased. Patients with total PSQI score higher than 5 had statistically significantly higher erythrocyte sedimentation rates (ESR), serum C-reactive protein and serum amyloid levels during attacks, more attack numbers in last 3 months and worse fatigue, depression scores. Total PSQI score was positively correlated with inflammatory markers during attacks, attack numbers in the last 3 months and fatigue score. Logistic regression models identified disease duration, ESR during attacks, fatigue, attack numbers in the last 3 months as predictors of poor sleep quality.
CONCLUSION: Poor sleep quality is common in adult FMF patients. Anxiety, depression and fatigue are more frequent in FMF patients than healthy individuals. Poor sleep quality is associated with inflammatory marker levels during attacks, fatigue and attack numbers in the last 3 months.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  disease activity; familial Mediterranean fever; fatigue; mood disorders; sleep disturbances

Mesh:

Year:  2017        PMID: 28560764     DOI: 10.1111/1756-185X.13104

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

1.  Decreased serum vitamin B12 and vitamin D levels affect sleep quality in children with familial Mediterranean fever.

Authors:  Rabia Miray Kisla Ekinci; Sibel Balci; Mahir Serbes; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Rheumatol Int       Date:  2017-11-15       Impact factor: 2.631

2.  Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever.

Authors:  David Piskin; Zehra Serap Arici; Dilek Konukbay; Micol Romano; Balahan Makay; Nuray Ayaz; Yelda Bilginer; Roberta A Berard; Hakan Poyrazoglu; Ozgur Kasapcopur; Ronald M Laxer; Kathy Speechley; Erkan Demirkaya
Journal:  Front Pediatr       Date:  2022-04-27       Impact factor: 3.569

3.  Familial Mediterranean fever: Health-related quality of life and associated variables in a national cohort.

Authors:  Hatice Bodur; Fatma Gül Yurdakul; Mehmet Tuncay Duruöz; Hasan Fatih Çay; Ülkü Uçar; Yaşar Keskin; Betül Sargin; Gülcan Gürer; Ozan Volkan Yurdakul; Mustafa Çaliş; Hülya Deveci; Yıldıray Aydin; Sami Hizmetli; Remzi Çevik; Ali Yavuz Karahan; Şebnem Ataman; Hilal Ecesoy; Zafer Günendi; Murat Toprak; Nesrin Şen; Duygu Altintaş; Ahmet Kıvanç Cengiz; Gökhan Çağlayan; Ali Nail Demir; Hüseyin Kaplan; Sertaç Ketenci; Meltem Alkan Melikoğlu; Mehmet Nayimoğlu; Kemal Nas; Banu Sarifakioğlu; İlhan Sezer
Journal:  Arch Rheumatol       Date:  2020-12-10       Impact factor: 1.472

Review 4.  Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.

Authors:  Caroline Vinit; Sophie Georgin-Lavialle; Aikaterini Theodoropoulou; Catherine Barbier; Alexandre Belot; Manel Mejbri; Pascal Pillet; Jana Pachlopnik; Sylvaine Poignant; Charlotte Rebelle; Andreas Woerner; Isabelle Koné-Paut; Véronique Hentgen
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.